Guangzhou Baiyunshan Baidi Biopharmaceutical

Guangzhou Baiyunshan Baidi Biopharmaceutical is a core subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings, specializing in the research, development, and manufacturing of biological products. Established in 2001, the company focuses on genetic engineering, vaccine development, and diagnostic reagents. Its flagship commercial product is a recombinant human epidermal growth factor (rhEGF) used for wound healing and skin repair. The company maintains a robust pipeline of therapeutic vaccines, including candidates for hepatitis B and rabies. Baidi Biopharmaceutical operates high-tech R&D centers and GMP-certified manufacturing facilities to support its biopharmaceutical innovations. It plays a pivotal role in the biological medicine segment of the larger Guangzhou Pharmaceutical Group.